
AstraZeneca
AZNCF | OTC
$189.90
-$2.60 (-1.35%)
Mar 13, 2026, 9:30 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 29, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 4.92B | 7.56B | 5.71B | 8.14B | 7.06B | 5.24B | 5.48B | 4.79B | 6.92B | 7.79B | 5.79B | 4.85B | 5.64B | 6.23B | 6.17B | 4.42B | 4.81B | 5.74B | 6.3B | 7.08B | 15.57B | 7.65B |
Short-Term Investments | 75.39M | 115M | 30M | 39M | 50.04M | 165.38M | 165.83M | 132.7M | 160.2M | 180M | 120.97M | 243.15M | 147.42M | 229.93M | 77M | 436.08M | 69.97M | 60.77M | 68.72M | 82.15M | 62.01M | 129.18M |
Long-Term Investments | 4.69B | 4.23B | 5.74B | 2.29B | 4.85B | 3.04B | 2.55B | 3.37B | 2.9B | 2.64B | 2.32B | 2.19B | 2.05B | 2.03B | 1.14B | 1.99B | 2.17B | 2.18B | 1.84B | 2.49B | 1.81B | 1.73B |
Other Long-Term Assets | 1.52B | 1.53B | -2.09M | 2.91B | -3.79M | -6.96M | 457.59M | 7.61M | -3.66M | 17.12M | 385.84M | 7.66M | 8.13M | 628K | 909M | 17.85M | 1.04M | 8.45M | 398.52M | -4.48M | -388K | -2.35M |
Receivables | 16.07B | 14.11B | 15.18B | 14.34B | 15.18B | 14.85B | 13.08B | 13.52B | 12.64B | 12.15B | 11.83B | 11.96B | 11.88B | 10.79B | 9.19B | 9.97B | 9.61B | 9.02B | 8.76B | 8.87B | 6.84B | 6.64B |
Inventory | 6.97B | 6.57B | 6.56B | 6.59B | 6.47B | 5.9B | 5.28B | 5.65B | 5.67B | 5.3B | 5.38B | 5.27B | 5.03B | 4.97B | 4.7B | 5.03B | 6.22B | 7.59B | 8.95B | 10.55B | 4.76B | 4.28B |
Other Current Assets | 76.4M | 1.26B | 1.25B | 827M | 195.15M | 45.1M | 53.94M | 15.97M | 28.04M | 10.93M | 115.02M | 96.66M | 43.83M | 39.99M | 1.13B | 185.34M | 197.91M | 149.42M | 553.73M | 160.29M | 41.01M | 64.09M |
Total Current Assets | 28.11B | 29.61B | 28.72B | 29.94B | 28.96B | 26.2B | 25.8B | 24.1B | 25.43B | 25.43B | 24.84B | 22.42B | 22.75B | 22.26B | 22.59B | 20.04B | 20.91B | 22.56B | 26.14B | 26.74B | 27.28B | 18.76B |
Property-Plant & Equipment | 16.38B | 14.94B | 14.7B | 13.78B | 13.23B | 12.3B | 11.65B | 11.51B | 10.83B | 10.55B | 10.41B | 9.7B | 9.62B | 9.6B | 9.45B | 9.23B | 9.63B | 10.02B | 10.17B | 10.16B | 9.03B | 8.85B |
Goodwill & Intangibles | 59.21B | 58.1B | 59.09B | 59.41B | 59.15B | 58.68B | 58.2B | 60.53B | 60.49B | 58.81B | 58.14B | 57.63B | 58.29B | 59.29B | 59.13B | 59.29B | 59.72B | 61.23B | 62.38B | 64.19B | 31.8B | 32.11B |
Total Long-Term Assets | 88.32B | 84.4B | 85.35B | 84.52B | 83.48B | 80.11B | 78.21B | 80.77B | 78.95B | 76.7B | 76.07B | 73.59B | 73.7B | 74.42B | 73.89B | 73.96B | 75.66B | 77.63B | 79.12B | 80.53B | 46.37B | 46.19B |
Total Assets | 116.43B | 114.02B | 114.07B | 114.46B | 112.42B | 106.25B | 104.04B | 104.92B | 104.34B | 102.29B | 101.12B | 96.09B | 96.54B | 96.69B | 96.48B | 94.19B | 96.58B | 100.27B | 105.36B | 107.22B | 73.64B | 64.93B |
Account Payables | 23.01B | 22.51B | 25.28B | 25.03B | 23.99B | 22.54B | 22.47B | 21.68B | 20.46B | 19.7B | 3.27B | 20.54B | 19.74B | 19.21B | 2.55B | 17.69B | 17.82B | 17.86B | 2.82B | 18.66B | 17.73B | 17.37B |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 6.27B | 7.58B | 3.1B | 6.17B | 6.49B | 3.05B | 2.16B | 1.25B | 5.07B | 6.05B | 5.13B | 5.37B | 4.56B | 3.63B | 5.31B | 5.41B | 2.16B | 2.07B | 1.66B | 2.74B | 2.7B | 2.04B |
Other Current Liabilities | 962.97M | 807M | 767M | 1.21B | 1.27B | 1.52B | 1.5B | 1.2B | 1.22B | 1.24B | 17.52B | 1.28B | 650M | 590M | 14.91B | 445M | 631M | 1.46B | 14.84B | 1.03B | 819M | 891M |
Total Current Liabilities | 31.72B | 32.57B | 30.62B | 34.05B | 33.54B | 29.13B | 27.87B | 25.93B | 28.57B | 28.9B | 30.54B | 28.59B | 26.38B | 24.86B | 26.29B | 24.85B | 21.82B | 22.74B | 22.59B | 23.65B | 22.22B | 21.51B |
Long-Term Debt | 23.81B | 24.45B | 24.72B | 24.7B | 24.71B | 26.69B | 26.51B | 28.89B | 27.23B | 27.26B | 22.37B | 22.23B | 24.33B | 26.92B | 22.97B | 23.01B | 26.46B | 28.08B | 28.13B | 28.21B | 24.11B | 17.41B |
Other Long-Term Liabilities | 4.47B | 4.63B | 5.1B | 4.75B | 4.48B | 4.55B | 4.37B | 4.63B | 4.67B | 5.05B | 5.34B | 4.56B | 4.9B | 5.58B | 6.48B | 7.02B | 6.39B | 6.74B | 8.36B | 8.32B | 8.2B | 8.27B |
Total Long-Term Liabilities | 34.09B | 34.06B | 34.74B | 34.43B | 34.08B | 35.99B | 35.3B | 38.19B | 36.18B | 35.89B | 31.41B | 30.28B | 32.75B | 36.02B | 33.13B | 34.18B | 38.81B | 41.17B | 43.48B | 43.66B | 35.73B | 28.97B |
Total Liabilities | 65.8B | 66.63B | 65.36B | 68.49B | 67.61B | 65.12B | 63.16B | 64.12B | 64.74B | 64.79B | 61.95B | 58.87B | 59.13B | 60.88B | 59.43B | 59.03B | 60.63B | 63.91B | 66.08B | 67.31B | 57.95B | 50.48B |
Total Debt | 32.41B | 33.92B | 29.62B | 32.66B | 32.84B | 31.29B | 30.11B | 31.56B | 33.53B | 34.55B | 28.62B | 28.58B | 29.84B | 31.5B | 29.23B | 29.3B | 29.53B | 31.1B | 30.78B | 31.91B | 27.5B | 20.13B |
Book Value | 50.63B | 47.38B | 48.72B | 45.97B | 44.81B | 41.13B | 40.87B | 40.81B | 39.6B | 37.5B | 39.17B | 37.22B | 37.42B | 35.81B | 37.06B | 35.15B | 35.95B | 36.36B | 39.29B | 39.91B | 15.69B | 14.45B |
Book Value Per Share | 32.46 | 30.35 | 31.17 | 29.45 | 28.74 | 26.35 | 26.17 | 26.16 | 25.38 | 24.04 | 25.09 | 23.86 | 23.98 | 22.96 | 23.77 | 22.55 | 23.05 | 23.29 | 25.40 | 26.68 | 11.91 | 10.95 |
Common Stock | 390.01M | 388M | 388M | 388M | 388M | 388M | 388M | 388M | 388M | 388M | 388M | 387M | 387M | 387M | 387M | 387M | 387M | 387M | 387M | 387M | 328M | 328M |
Retained Earnings | 12.66B | 9.67B | 10.97B | 8.21B | 7.02B | 3.36B | 3.16B | 3.14B | 1.85B | -212M | 1.5B | -434M | -234M | -1.83B | -574M | -2.47B | -1.66B | -1.23B | 1.71B | 2.2B | 5.34B | 4.09B |
Comprehensive Income | 2.04B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | 50.56B | 47.33B | 48.67B | 45.89B | 44.72B | 41.04B | 40.79B | 40.72B | 39.51B | 37.45B | 39.14B | 37.2B | 37.39B | 35.79B | 37.04B | 35.13B | 35.93B | 36.34B | 39.27B | 39.74B | 15.68B | 14.43B |
Total Investments | 4.76B | 4.35B | 5.77B | 2.33B | 4.9B | 3.21B | 2.72B | 3.5B | 3.06B | 2.81B | 2.44B | 2.44B | 2.2B | 2.26B | 1.22B | 2.42B | 2.24B | 2.24B | 1.9B | 2.57B | 1.87B | 1.86B |
Add to Watchlist
Select watchlists to add or remove AZNCF